NTRR Explores Developing All-Natural Alternative to Adderall
July 24 2014 - 7:26AM
Business Wire
In its mission to deliver all-natural, cutting-edge wellness
solutions, Neutra Corp. (OTCBB: NTRR) is exploring the development
of an herbal supplement alternative to the drug Adderall.
Adderall is an effective and widely-prescribed drug used to
treat narcolepsy and ADHD. Like many prescription drugs, however,
Adderall can be habit-forming and produce undesirable side-effects
such as high blood pressure, tremors, hallucinations, nausea, sleep
problems, anxiety and many more. By developing an over-the-counter
supplement using only all-natural ingredients, NTRR believes it can
provide a better solution.
“Our goal would be the development of a capsule that can provide
many of the benefits of Adderall without the dangerous side-effects
and potential for addiction,” said NTRR CEO Sydney Jim. “We’re
currently seeking out potential development partners who can help
us produce a new nutraceutical that can change the lives of people
currently addressing various wellness issues with Adderall and
other expensive prescriptions.”
Neutra Corp. is dedicated to commercializing innovative,
all-natural products to compete in the fast-growing wellness sector
alongside Herbalife Ltd. (NYSE: HLF), Vitamin Shoppe
(NYSE: VSI), Nutraceutical International Corp.
(NASDAQ: NUTR) and Schiff Nutrition International Inc.
(NYSE: WNI).
About Neutra Corp.
Neutra Corp. is a healthy lifestyle company that
specializes in the development and marketing of natural
wellness solutions, including cannabis-related products and
services as well as protective, anti-microbial coatings for indoor
and outdoor surfaces. For investing information and performance
data, please visit www.neutracorp.com.
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation
Reform Act of 1995: This news release contains forward-looking
information within the meaning of Section 27A of the Securities Act
of 1933, as amended, and Section 21E of the Securities Exchange Act
of 1934, as amended, including statements that include the words
"believes," "expects," "anticipate" or similar expressions.
Such forward-looking statements involve known and unknown
risks, uncertainties and other factors that may cause the actual
results, performance or achievements of the company to differ
materially from those expressed or implied by such forward-looking
statements. In addition, description of anyone's past success,
either financial or strategic, is no guarantee of future success.
This news release speaks as of the date first set forth above and
the company assumes no responsibility to update the information
included herein for events occurring after the date hereof.
Neutra Corp.Sydney Jim, 813-367-2041President and
CEOinfo@neutracorp.com
Neutra (PK) (USOTC:NTRR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Neutra (PK) (USOTC:NTRR)
Historical Stock Chart
From Apr 2023 to Apr 2024